News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
638,668 Results
Type
Article (60986)
Company Profile (75)
Press Release (577607)
Section
Business (173484)
Career Advice (2725)
Deals (32394)
Drug Delivery (95)
Drug Development (76713)
Employer Resources (149)
FDA (14882)
Job Trends (13863)
News (304478)
Policy (28912)
Tag
Academia (2874)
Alliances (43003)
Alzheimer's disease (1251)
Approvals (14878)
Artificial intelligence (204)
Bankruptcy (286)
Best Places to Work (10860)
Breast cancer (223)
Cancer (1659)
Cardiovascular disease (120)
Career advice (2305)
CAR-T (124)
Cell therapy (356)
Clinical research (61737)
Collaboration (622)
Compensation (226)
COVID-19 (2546)
C-suite (173)
Data (1593)
Diabetes (195)
Diagnostics (6068)
Earnings (59015)
Employer resources (132)
Events (92981)
Executive appointments (590)
FDA (15782)
Funding (600)
Gene therapy (239)
GLP-1 (604)
Government (4407)
Healthcare (18167)
Infectious disease (2647)
Inflammatory bowel disease (120)
Interviews (524)
IPO (14739)
Job creations (3413)
Job search strategy (1940)
Layoffs (469)
Legal (6440)
Lung cancer (241)
Manufacturing (213)
Medical device (12553)
Medtech (12558)
Mergers & acquisitions (18069)
Metabolic disorders (501)
Neuroscience (1641)
NextGen: Class of 2025 (6377)
Non-profit (4316)
Northern California (1875)
Obesity (266)
Opinion (219)
Patents (158)
People (59053)
Phase I (19417)
Phase II (27258)
Phase III (19884)
Pipeline (671)
Postmarket research (2468)
Preclinical (8221)
Radiopharmaceuticals (243)
Rare diseases (306)
Real estate (5978)
Regulatory (19739)
Research institute (2387)
Resumes & cover letters (405)
Southern California (1652)
Startups (3338)
United States (16872)
Vaccines (587)
Weight loss (176)
Date
Today (24)
Last 7 days (542)
Last 30 days (2439)
Last 365 days (31737)
2025 (4214)
2024 (32275)
2023 (36328)
2022 (46612)
2021 (51565)
2020 (50724)
2019 (44789)
2018 (34071)
2017 (30715)
2016 (30065)
2015 (35440)
2014 (28389)
2013 (24953)
2012 (26214)
2011 (26462)
2010 (24930)
Location
Africa (869)
Arizona (152)
Asia (37719)
Australia (6794)
California (4295)
Canada (1571)
China (361)
Colorado (200)
Connecticut (217)
Europe (87690)
Florida (647)
Georgia (159)
Illinois (466)
Indiana (234)
Japan (112)
Maryland (694)
Massachusetts (3131)
Michigan (200)
Minnesota (286)
New Jersey (1278)
New York (1250)
North Carolina (828)
Northern California (1875)
Ohio (163)
Pennsylvania (978)
South America (1175)
Southern California (1652)
Texas (656)
Utah (135)
Washington State (428)
638,668 Results for "university of missouri".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AI Proteins Enters into Collaborative Research Agreement with the University of Missouri on Radioligand Therapy
January 8, 2025
·
2 min read
BioMidwest
University of Missouri Laboratory for Infectious Disease Study Finds Technology Used in Widely Deployed Fingerprint Scanners Kills The Virus that Causes COVID-19
Researchers at the University of Missouri Laboratory for Infectious Disease Research released the results of a study indicating that electroluminescent film technology, found in widely deployed biometric fingerprint scanners, actively kills SARS-CoV-2.
May 9, 2023
·
4 min read
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023.
June 27, 2023
·
7 min read
Business
Express Scripts Sues FTC, Demands Withdrawal of ‘False and Misleading’ PBM Report
Pharmacy benefit manager Express Scripts announced Tuesday it has filed a lawsuit in federal court in Missouri against the Federal Trade Commission for its “unfair, biased and erroneous” July report on the industry.
September 17, 2024
·
2 min read
·
Kate Goodwin
Drug Development
QSAM Biosciences Recruits the Ellis Fischel Cancer Center at the University of Missouri as Clinical Trial Site to Further Expand and Advance the Study of CycloSam® for Bone Cancer
QSAM Biosciences Inc. (OTCQB: QSAM) today announces the addition of the Ellis Fischel Cancer Center (EFCC) at the University of Missouri (MU) School of Medicine (SOM) as an upcoming clinical trial site to soon begin enrolling participants into the Phase 1 study evaluating CycloSam® for participants with multiple types of bone cancer that either originated in or has metastasized to the bone.
February 22, 2023
·
6 min read
BioForest
Pelvic Fragility Fracture Patient at the University of Missouri in Columbia is the 100th Person Treated with CurvaFix IM Implant for Pelvic Fracture Fixation
CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, announced the completion of the 100th surgical procedure using the CurvaFix® IM Implant to repair a pelvic fragility fracture for a geriatric patient at University Hospital at the University of Missouri in Columbia, Mo.
September 6, 2022
·
4 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Drug Development
Vivacelle Bio and University of Missouri-Kansas City School of Medicine Announce Groundbreaking Results from Phase 2a Clinical Trial of VBI-S for Refractory Hypotension in Severe Septic Shock Patients
Today, researchers at Vivacelle Bio, Inc., a pioneering biotechnology company revealed the compelling outcomes of their phase 2a clinical trial of the investigational cardiovascular support fluid, VBI-S, in patients with severe septic shock.
February 29, 2024
·
5 min read
Business
Meridian Medical Technologies, a Kindeva Drug Delivery Company, Investing $100+ Million in Bridgeton, Missouri, Expansion
Meridian Medical Technologies announced , during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next four years in a newly purchased facility.
April 11, 2023
·
6 min read
Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri
Altasciences is pleased to announce the completion of its laboratory facilities in Columbia, MO.
October 31, 2023
·
2 min read
1 of 63,867
Next
